Attached files
file | filename |
---|---|
8-K - 8-K - KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | acucela8-k_20160527xcoaeyl.htm |
Exhibit 16.1
May 27, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated May 27, 2016, of Acucela Inc. and are in agreement with the statements contained in the first, second and third paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP